Copyright © 2004 Elsevier B.V. All rights reserved.
Sensitive liquid chromatography–tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma
Received 30 September 2004;
Abstract
A rapid and sensitive method for the simultaneous determination of paracetamol and guaifenesin in human plasma was developed and validated, using high-performance liquid chromatographic separation with tandem mass spectrometric detection. After extracted from plasma samples by diethyl ether–dichloromethane (3:2, v/v), the analytes and internal standard osalmide were chromatographed on a C18 column. Detection was performed on a triple quadrupole tandem mass spectrometer by selected reaction monitoring (SRM) mode via atmospheric pressure chemical ionization (APCI). The method was linear in the concentration range of 0.05–20.0 μg/ml for paracetamol and 5.0–2000.0 ng/ml for guaifenesin. The intra- and inter-day precision was within 14% for both paracetamol and guaifenesin. The assay accuracy was within ±2.4% for the analytes. This is the first assay method described for the simultaneous determination of paracetamol and guaifenesin in plasma using one chromatographic run. The method was successfully employed in a pharmacokinetic study after an oral administration of a multicomponent formulation, containing 650 mg paracetamol, 200 mg guaifenesin, 60 mg pseudoephedrine and 20 mg dextrorphan.
Keywords: Paracetamol; Guaifenesin
Article Outline
- 1. Introduction
- 2. Experimental
- 2.1. Materials
- 2.2. Instrumentation
- 2.3. LC–MS–MS conditions
- 2.4. Preparation of standard and quality control samples
- 2.5. Sample preparation
- 2.6. Method validation
- 2.7. Pharmacokinetic study
- 3. Results and discussion
- 3.1. Mass spectrometry
- 3.2. Chromatography
- 3.3. Method validation
- 3.3.1. Selectivity
- 3.3.2. Matrix effect
- 3.3.3. Linearity of calibration curves and lower limits of quantification (LLOQ)
- 3.3.4. Precision and accuracy
- 3.3.5. Extraction recovery and stability
- 3.4. Application of the method to pharmacokinetic study in healthy volunteers
- 4. Conclusions
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (10)








